SCHEMBL23770765

SCHEMBL23770765

COc1ccc(F)cc1-c1nc(NSc2cccc(N3CCN(C(C)(C)C)CC3)n2)ccc1C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.35
MAPK1 P28482 2/20 0.33
GALR2 O43603 1/20 0.33
GALR1 P47211 1/20 0.33
TP53 P04637 1/20 0.33
PDE4B Q07343 1/20 0.33
ATR Q13535 1/20 0.32
ATRIP Q8WXE1 1/20 0.32
LRRK2 Q5S007 3/20 0.32
ALDH1A1 P00352 2/20 0.32
USP2 O75604 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
NR3C1 P04150 1/20 0.32
PGR P06401 1/20 0.32
PHGDH O43175 2/20 0.31
TNIK Q9UKE5 1/20 0.31
RAF1 P04049 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770826 0.92 S1PR1 (0.41) S1PR1MAPK1GALR2GALR1TP53
SCHEMBL29464476 0.83 NR3C1 (0.37) S1PR1GALR2GALR1TP53NR3C1
SCHEMBL19925790 0.83 NR3C1 (0.37) S1PR1GALR2GALR1TP53NR3C1
SCHEMBL23770593 0.82 GALR2 (0.33) GALR2GALR1ALDH1A1CYP1A2CYP3A4
SCHEMBL23770466 0.81 CYP1A2 (0.37) ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL23770452 0.80 PDE10A (0.34) S1PR1GALR2GALR1TP53
SCHEMBL23770770 0.78 ADRB2 (0.38) ALDH1A1CYP1A2CYP2C19RAF1BRAF
SCHEMBL23770877 0.76 RBP4 (0.35) TP53ALDH1A1CYP1A2CYP2C19RAF1
SCHEMBL23770632 0.75 ADRB2 (0.42) ALDH1A1CYP1A2CYP2C19WDR5
SCHEMBL23770671 0.74 GALR2 (0.39) GALR2GALR1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed